Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Companies

Results 1 - 1 out of 1 displayed.
 
Search filter:
  • Search for: Company
Sort direction:
Sort direction:
 |   |   | 
Headquarters
Berkeley, California, USA
Main sector:
  • Biotechnology - Therapeutics and Diagnostics
Subsector:
  • Cell therapy
  • Immunotherapy
Indications:
  • Neoplasms / cancer / oncology
  • Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Employees:
  • Worldwide: 158
Products:
  • In development: 5
Description:
Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company’s genome-editing platform, including its Cas12a chRDNA technology, enables superior precision to develop cell therapies that are armored to potentially improve antitumor activity. CB-010 is the company's lead clinical-stage program and is an allogeneic anti-CD19 CAR-T cell therapy for the treatment of patients...

Already have a valid Biotechgate account? Login here »

Get access to Biotechgate

Download complete company profiles including product pipelines, financing rounds and management details.


to the top ↑